DK1652848T3 - Fremgangsmåde til fremstilling af imidforbindelse - Google Patents

Fremgangsmåde til fremstilling af imidforbindelse

Info

Publication number
DK1652848T3
DK1652848T3 DK04748182.5T DK04748182T DK1652848T3 DK 1652848 T3 DK1652848 T3 DK 1652848T3 DK 04748182 T DK04748182 T DK 04748182T DK 1652848 T3 DK1652848 T3 DK 1652848T3
Authority
DK
Denmark
Prior art keywords
imide compound
preparation
producing
formula
compound hydrochloride
Prior art date
Application number
DK04748182.5T
Other languages
English (en)
Inventor
Yuzo Kakiya
Mayumi Oda
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34100970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1652848(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of DK1652848T3 publication Critical patent/DK1652848T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DK04748182.5T 2003-07-29 2004-07-27 Fremgangsmåde til fremstilling af imidforbindelse DK1652848T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003281860 2003-07-29
PCT/JP2004/011035 WO2005009999A1 (ja) 2003-07-29 2004-07-27 イミド化合物の製造方法

Publications (1)

Publication Number Publication Date
DK1652848T3 true DK1652848T3 (da) 2012-02-27

Family

ID=34100970

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04748182.5T DK1652848T3 (da) 2003-07-29 2004-07-27 Fremgangsmåde til fremstilling af imidforbindelse

Country Status (12)

Country Link
US (2) USRE45573E1 (da)
EP (1) EP1652848B1 (da)
JP (1) JP4610485B2 (da)
KR (1) KR101085806B1 (da)
CN (1) CN100422178C (da)
AT (1) ATE543817T1 (da)
AU (1) AU2004259305B2 (da)
BR (1) BRPI0413081B8 (da)
CA (1) CA2538265C (da)
DK (1) DK1652848T3 (da)
ES (1) ES2378990T3 (da)
WO (1) WO2005009999A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006134864A1 (ja) * 2005-06-13 2006-12-21 Dainippon Sumitomo Pharma Co., Ltd. 可溶化型製剤
JP5097265B2 (ja) 2007-04-04 2012-12-12 メルク・シャープ・エンド・ドーム・コーポレイション 治療薬
WO2011093522A1 (en) * 2010-01-28 2011-08-04 Dainippon Sumitomo Pharma Co., Ltd. A cycloalkane derivative
EP2563790B1 (en) 2010-04-26 2016-09-14 Sumitomo Dainippon Pharma Co., Ltd. A process of a quaternary ammonium salt
WO2012053654A1 (en) * 2010-10-18 2012-04-26 Dainippon Sumitomo Pharma Co., Ltd. Sustained-release formulation for injection
WO2012107890A2 (en) 2011-02-10 2012-08-16 Ranbaxy Laboratories Limited Crystalline forms of lurasidone hydrochloride
WO2012123858A1 (en) 2011-03-14 2012-09-20 Ranbaxy Laboratories Limited Amorphous lurasidone hydrochloride
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
CZ304027B6 (cs) * 2011-08-18 2013-08-28 Farmak, A. S. Zpusob prípravy polymorfu (1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl]-1-cyklohexylmethyl]-2,3-bicyklo[2.2.1]heptandikarboximidu hydrochloridu
CN102952064A (zh) * 2011-08-19 2013-03-06 天津药物研究院 一种医药中间体顺式-外-二环[2.2.1]庚烷-2.3-二甲酰亚胺的制备方法
WO2013030722A1 (en) 2011-08-26 2013-03-07 Ranbaxy Laboratories Limited Crystalline lurasidone hydrochloride
CN103130795A (zh) * 2011-12-02 2013-06-05 苏州二叶制药有限公司 卢拉西酮盐酸盐的晶体a及其用途
CN103130794B (zh) * 2011-12-02 2016-06-22 苏州二叶制药有限公司 卢拉西酮盐酸盐的晶体a的制备方法
WO2013121440A1 (en) 2012-02-13 2013-08-22 Cadila Healthcare Limited Process for preparing benzisothiazol-3-yl-peperazin-l-yl-methyl-cyclo hexyl-methanisoindol-1,3-dione and its intermediates
CN103360383B (zh) * 2012-04-11 2016-07-06 上海医药工业研究院 鲁拉西酮盐酸盐的晶型b及其制备方法
CN102746289B (zh) * 2012-04-28 2016-06-08 上海医药工业研究院 一种盐酸卢拉西酮的制备方法
WO2013190455A2 (en) * 2012-06-18 2013-12-27 Shasun Pharmaceuticals Limited Process for the preparation of lurasidone hydrochloride
CN102863437A (zh) * 2012-09-04 2013-01-09 济南百诺医药科技开发有限公司 一种鲁拉西酮的制备方法
WO2014064714A2 (en) * 2012-10-22 2014-05-01 Glenmark Pharmaceuticals Limited; Glenmark Generics Limited Process for preparation of lurasidone hydrochloride
CN102911170A (zh) * 2012-11-15 2013-02-06 苏州第壹制药有限公司 酰亚胺化合物盐酸盐的制备方法
CN105524057A (zh) * 2013-03-06 2016-04-27 江苏恩华药业股份有限公司 盐酸鲁拉西酮的新晶型及其制备方法
CN103539794A (zh) * 2013-10-17 2014-01-29 常州大学 一种盐酸鲁拉西酮的成盐方法
CZ306203B6 (cs) 2013-12-06 2016-09-29 Zentiva, K. S Způsob syntézy lurasidonu
CA2951917C (en) 2014-06-16 2019-09-24 Johnson Matthey Public Limited Company Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates
WO2016059649A1 (en) 2014-10-14 2016-04-21 Jubilant Generics Limited (Formerly Jubilant Life Sciences Division) An improved process for the preparation of lurasidone hydrochloride
CN111989101A (zh) 2018-02-28 2020-11-24 大日本住友制药株式会社 具有受控溶出的水性悬浮液型药物制剂
CN111989102A (zh) 2018-02-28 2020-11-24 大日本住友制药株式会社 水性混悬液型药物制剂
CN115950695B (zh) * 2021-10-09 2023-07-28 北京阳光诺和药物研究股份有限公司 一种制备鲁拉西酮基毒杂质的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS517440A (da) * 1974-07-08 1976-01-21 Japan Storage Battery Co Ltd
JPS57197265A (en) 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
AU615966B2 (en) 1987-12-04 1991-10-17 Takeda Chemical Industries Ltd. Crystals of cephem hydrochloride
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5663381A (en) 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US6673942B1 (en) 2000-02-11 2004-01-06 Degussa Ag Resolution of DL-racemic mixtures
AU2001246861A1 (en) * 2000-04-10 2001-10-23 Sumitomo Pharmaceuticals Co. Ltd. Sustained release preparations
CA2431041A1 (en) * 2001-01-02 2002-07-11 Pharmacia & Upjohn Company New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents

Also Published As

Publication number Publication date
JP4610485B2 (ja) 2011-01-12
EP1652848A4 (en) 2009-04-15
US7605260B2 (en) 2009-10-20
ES2378990T3 (es) 2012-04-19
AU2004259305A1 (en) 2005-02-03
CN1832946A (zh) 2006-09-13
EP1652848A1 (en) 2006-05-03
KR101085806B1 (ko) 2011-11-22
EP1652848B1 (en) 2012-02-01
BRPI0413081A (pt) 2006-10-03
AU2004259305B2 (en) 2009-06-04
BRPI0413081B1 (pt) 2018-03-20
BRPI0413081B8 (pt) 2021-05-25
JPWO2005009999A1 (ja) 2006-09-07
CA2538265C (en) 2012-10-02
WO2005009999A1 (ja) 2005-02-03
KR20060052840A (ko) 2006-05-19
US20060194970A1 (en) 2006-08-31
ATE543817T1 (de) 2012-02-15
CA2538265A1 (en) 2005-02-03
CN100422178C (zh) 2008-10-01
USRE45573E1 (en) 2015-06-23

Similar Documents

Publication Publication Date Title
DK1652848T3 (da) Fremgangsmåde til fremstilling af imidforbindelse
ATE544744T1 (de) Verfahren zur herstellung von benzoesaure derivaten
BRPI0519726A2 (pt) formas cristalinas do cloridrato de (r)-8-cloro-1-metil-2,3,4,5-tetraidro-1h-3-benzazepina
SE0202838D0 (sv) Chemical compounds
CY1106969T1 (el) Αναστολεις dpp-iv
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
DK1537097T3 (da) Fremgangsmåde til fremstilling af 3-Halo-4,5-dihydro-1H-pyrazoler
ECSP055913A (es) Inhibidores de las polimerasas víricas
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
DE602006021397D1 (de) Verfahren zur herstellung von (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomethylcyclopropan
ATE423764T1 (de) Verfahren zur herstellung von hydrazon-derivaten
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
NO20053208D0 (no) Metode for reduktiv dehalogenering.
DE602006003204D1 (de) Reinigungsverfahren von Moxonidine
EP1571144A4 (en) HYDROXYALKYLATED CYCLIC DEDIAMINE COMPOUND
ATE380171T1 (de) Verfahren zur herstellung von terbinafine
DK1807401T3 (da) Fremgangsmåde til fremstilling af phenyl-2-pyrimidinylketoner samt deres nye mellemprodukter
WO2005056539A3 (en) A process for the resolution of nefopam
DE50304869D1 (de) Verfahren zur herstellung einer spezifischen kristallmodifikation von 2-(2-chlor-4-mesyl-benzoyl)-cyclohexan-1,3-dion
ATE516278T1 (de) Verfahren zur herstellung von amidverbindungen
ATE330946T1 (de) Verfahren zur herstellung einer benzylamin- verbindung
TH82166A (th) กระบวนการที่ดีขึ้นสำหรับการเตรียมไดไฮโดรเบนโซฟิวแรนที่ถูกแทนที่ด้วย(โพรพีนิลที่ถูกแทนที่สองตำแหน่ง)เฟนิลแอลคิล
DE602004012356D1 (de) Pyrrolpolymerzusammensetzungen
TH73864A (th) วิธีการสำหรับการเตรียมของ {2-[(8,9)-ไดออกโซ-2,6-ไดอะซา-ไบไซโคล [5.2.0]-นอน-1(7)-อีน-2-อิล]เอทธิล}ฟอสโฟนิก แอซิด และเอสเทอร์ของสิ่งเหล่านี้
TH61601A (th) 3-อัลคิเลตเทด-5,5',6,6',7,7',8,8'-ออคตะไฮโดร-2,2'-ไบแนฟธอล และ3,3'-ไดอัลคิเลตเทด-5,5',6,6',7,7'8,8'-ออคตะไฮโดร-2,2'-ไบแนฟธอล และกระบวนการสำหรับการผลิตพวกมัน